EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination

Richard S H Lee, Samuel M S Cheng, Jin Zhao, Annie Y S Tsoi, Kaman K M Lau, CoCo H C Chan, John K C Li, David S C Hui, Malik Peiris, Hui-Ling Yen iD

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.13309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Richard S H Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Cross Reactions, Antibodies, Viral, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Research Grants Council of the Hong Kong SAR Government, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The newly emerged SARS‐CoV‐2 possesses shared antigenic epitopes with other human coronaviruses. We investigated if COVID‐19 vaccination or SARS‐CoV‐2 infection may boost cross‐reactive antibodies to other human coronaviruses.

Methods

Prevaccination and postvaccination sera from SARS‐CoV‐2 naïve healthy subjects who received three doses of the mRNA vaccine (BioNTech, BNT) or the inactivated vaccine (CoronaVac, CV) were used to monitor the level of cross‐reactive antibodies raised against other human coronaviruses by enzyme‐linked immunosorbent assay. In comparison, convalescent sera from COVID‐19 patients with or without prior vaccination history were also tested. Pseudoparticle neutralization assay was performed to detect neutralization antibody against MERS‐CoV.

Results

Among SARS‐CoV‐2 infection−naïve subjects, BNT or CV significantly increased the anti‐S2 antibodies against Betacoronaviruses (OC43 and MERS‐CoV) but not Alphacoronaviruses (229E). The prevaccination antibody response to the common cold human coronaviruses did not negatively impact the postvaccination antibody response to SARS‐CoV‐2. Cross‐reactive antibodies that binds to the S2 protein of MERS‐CoV were similarly detected from the convalescent sera of COVID‐19 patients with or without vaccination history. However, these anti‐S2 antibodies do not possess neutralizing activity in MERS‐CoV pseudoparticle neutralization tests.

Conclusions

Our results suggest that SARS‐CoV‐2 infection or vaccination may potentially modulate population immune landscape against previously exposed or novel human coronaviruses. The findings have implications for future sero‐epidemiological studies on MERS‐CoV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross ReactionsAntibodies, ViralCOVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, NeutralizingHumansAdultMaleFemaleVaccinationMiddle AgedVaccines, InactivatedNeutralization TestsMiddle East Respiratory Syndrome CoronavirusYoung AdultmRNA Vaccines

Stichwörter der Autor:innen

COVID‐19 vaccinesSARS‐CoV‐2convalescent seracross‐reactive antibodyhuman coronaviruses

Substanzen

Antibodies, ViralCOVID-19 VaccinesAntibodies, NeutralizingVaccines, InactivatedmRNA Vaccines

Autor:innen und Institutionen

  • School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Department of Medicine and Therapeutics, CUHK, Prince of Wales Hospital, Hong Kong, China.
  • Centre for Immunology & Infection, Hong Kong Science Park, Hong Kong, China.

ORCID-Profile: Hui-Ling Yen

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Research Grants Council of the Hong Kong SAR Government, China

Zitieren

APA

Lee, R. S. H., Cheng, S. M. S., Zhao, J., Tsoi, A. Y. S., Lau, K. K. M., Chan, C. H. C., Li, J. K. C., Hui, D. S. C., Peiris, M., & Yen, H. L. (2024). Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13309

Vancouver

Lee RSH, Cheng SMS, Zhao J, Tsoi AYS, Lau KKM, Chan CHC, et al. Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13309

BibTeX
@article{Lee2024,
  author = {Lee, Richard S H and Cheng, Samuel M S and Zhao, Jin and Tsoi, Annie Y S and Lau, Kaman K M and Chan, CoCo H C and Li, John K C and Hui, David S C and Peiris, Malik and Yen, Hui-Ling},
  title = {Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.13309}
}
Kostenlos starten →